Hospital pharmacists' opinions on a risk prediction tool for medication-related harm in older people.

Authors:
Hussain A; Ali K; Davies JG; Stevenson JM; Lippett S and 3 more

Journal:
Br J Clin Pharmacol

Publication Year: 2022

DOI:
10.1111/bcp.15502

PMCID:
PMC10087672

PMID:
35986928

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel reti…
Goncalves MB; Mant T; Täubel J and 8 more (2023) - Transparency Score: 4/6
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastati…
Lehtisalo M; Taskinen S; Tarkiainen EK and 8 more (2022) - Transparency Score: 3/6
A crossover study evaluating the sex-dependent and sensitizing effects of sleep deprivation using a…
Hijma H; Koopmans I; Klaassen E and 3 more (2022) - Transparency Score: 4/6
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in pat…
Baakman AC; Gavan C; van Doeselaar L and 12 more (2022) - Transparency Score: 4/6
An e-Delphi study to obtain expert consensus on the level of risk associated with preventable e-pre…
Heed J; Klein S; Slee A and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST No conflicts of interest to declare."

Evidence found in paper:

"We would like to acknowledge the valuable contributions of all the pharmacists who agreed to participate in the semistructured interviews. There was no funding for this research."

Evidence found in paper:

"The study was presented and registered with the local Pharmacy Research and Audit Group at RSCH (reference: PRAGSEP20/01). It was deemed to be part of service evaluation of current pharmacy discharge processes and therefore not classified as “clinical research that required ethical approval”. Voluntary semistructured interviews with pharmacists included only discussion of hypothetical scenarios; there was no requirement for ethical approval."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025